Roivant Sciences earnings were -$219.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ROIV earnings report on Dec 31, 2024 announced Q4 2024 earnings of $66.8M, down 129% from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, ROIV reported annual earnings of $4.3B, with -531% growth.
What were Roivant Sciences's earnings last quarter?
On ROIV's earnings call on Invalid Date, Roivant Sciences (NASDAQ: ROIV) reported Q4 2024 earnings per share (EPS) of $0.23, up 96.39% year over year. Total ROIV earnings for the quarter were $66.77 million. In the same quarter last year, Roivant Sciences's earnings per share (EPS) was $6.37.
As of the last Roivant Sciences earnings report, Roivant Sciences is currently losing money. Roivant Sciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$219.23 million, a 104.96% decrease year over year.
What was ROIV's earnings growth in the past year?
As of Roivant Sciences's earnings date in Invalid Date, Roivant Sciences's earnings has grown year over year. ROIV earnings in the past year totalled -$219.23 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.